Sequencing Consumables Market Size, Share & Industry Analysis, By Offering (Kits {DNA Library Prep Kits, RNA Library Prep Kits, Target Enrichment Kits, & Others}, Reagents {Sample Preparation Reagents, Library Prep & Amplification Reagents & Others}, Sequencing Run Consumables {Flow Cells or Sequencing Chips, Reagent Cartridges, & Others}, and Accessories), By Sequencing Platform (Next-Generation Sequencing, Sanger Sequencing, & Others), By Application (Drug Discovery & Development, Clinical Diagnosis, Pharmacogenomics and Others), By End User, and Regional Forecast, 2026-2034

The global sequencing consumables market size was valued at USD 13.02 billion in 2025. The market is projected to grow from USD 13.96 billion in 2026 to USD 48.86 billion by 2034, exhibiting a CAGR of 16.95% during the forecast period.

The global market is experiencing steady and substantial growth. This market includes essential products such as reagents, buffers, enzymes, flow cells, and other disposable materials required for sequencing workflows. The pivotal role of sequencing is to enable high-throughput genetic analysis for genomics research, personalized medicine, and diagnostics. The rapid growth of Next-Generation Sequencing (NGS) technologies has significantly expanded the demand for these consumables. Furthermore, the rise of clinical applications, including cancer genomics and infectious disease monitoring, further propels the market growth.

• For instance, in November 2025, Princess Margaret Cancer Centre in Canada partnered with the genomics company Helix to launch the OurGenes Study. The study is set to enroll around 100,000 subjects over five years, to focus on precision medicine and early identification of hereditary health risks.

Moreover, many key industry players, such as Thermo Fisher Scientific Inc. and Agilent, are operating in the market, with innovative products to improve the efficiency, accuracy, and affordability of sequencing processes, thus fueling market expansion.

SEQUENCING CONSUMABLES MARKET TRENDS

Rising Demand for Targeted Panels and Enrichment Kits is Key Market Trend

The increasing demand for targeted panels and enrichment kits is a significant trend in the market. These products enable more precise analysis of specific genetic regions, making them essential for personalized medicine and diagnostic applications. Additionally, demand for faster turnaround times and higher accuracy boosted the adoption of targeted panels. Also, the rising focus of key players to launch new and advanced solutions and panels for NGS is propelling market growth during the forecast period.

• For instance, in July 2025, QIAGEN launched QIAseq xHYB Long Read Panels, a suite of target enrichment solutions for long-read sequencing of genomically complex regions. This new offering strengthens the company’s position that offers differentiated solutions for NGS platforms covering both short- and long-read technologies.

Download Free sample to learn more about this report.

MARKET DYNAMICS

MARKET DRIVERS

Pharma and Biotech Adoption of Precision Medicine is Driving Market Growth

The rising prevalence of chronic diseases and increasing demand for precision medicine are key drivers of the sequencing consumables market growth. As personalized treatments use individual genetic profiles, they require high-throughput sequencing technologies. Additionally, pharma and biotech companies are focused on advancing their portfolios through precision medicine and require extensive genomic data, further boosting the need for reliable and scalable sequencing solutions.

• For instance, in October 2024, the National Institutes of Health (NIH) launched a precision medicine clinical trial to test new treatment combinations targeting specific genetic changes in the cancer cells of people with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS).

MARKET RESTRAINTS

High Cost of Products to Restrict the Market Growth

A significant market restraint is the high cost per sample, driven by multiple consumables in sequencing workflows, including library prep kits, QC/quant reagents, flow cells, chips, and reagent cartridges. Additionally, stringent quality standards, additional controls, repeat runs, and validation processes collectively increase consumables usage. The cost associated with repeated runs and multiple products decreases adoption in mid-tier hospitals and diagnostic laboratories, thus restraining market growth.

• For instance, in October 2024, PacBio announced SPRQ chemistry for the Revio system and highlighted a major advancement, reducing the cost of a HiFi human genome to less than USD 500 per sample, thereby showing that lowering per-sample consumables costs is critical to expanding adoption.

MARKET OPPORTUNITIES

Focus on Population Genomics and Preventive Screening Programs Generate Market Growth Opportunities

The expanding focus on population genomics and preventive screening programs, along with the rising demand for preventive care, is offering lucrative growth opportunities for the market. As governments and healthcare providers emphasize early disease detection and personalized medicine, demand for high-throughput sequencing reagents, kits and consumables is increasing. Additionally, the rise in preventive health strategies and government programs, also boosts the market growth.

• For instance, in July 2025, the U.K. Government released a 10-Year Health Plan for England that highlights a stronger emphasis on prevention through the development of a genomics-based population health service, aimed at early detection and intervention for high-risk individuals.

MARKET CHALLENGES

Supply Chain Constraint Challenges the Market Growth

Supply-chain constraints on key reagents and single-source components pose a significant challenge for the market. Limited supply of critical reagents and disruptions due to geopolitical issues, natural disasters, or production delays severely impact availability and raise product prices. Additionally, supply shortages, delays, and price volatility, can hinder the timely production and deployment of sequencing kits and reagents.

Segmentation Analysis

By Offerings

Recurring Demand for Sequencing Run Consumables to Propel Segment’s Growth

Based on the offerings, the market is categorized into kits, reagents, sequencing run consumables and accessories.

The sequencing run consumables segment is expected to account for the largest share of the market. The segment accounted for 40.1% of the market in 2025. This is driven by exclusive design, high performance and the necessity of each run, which creates recurring demand.

• For instance, in February 2025, F. Hoffmann-La Roche introduced Sequencing by Expansion (SBX) technology, which offers ultra-rapid, high-throughput sequencing that is both flexible and scalable across various genomic applications.

The reagents segment is expected to grow at a CAGR of 14.18% for market over the forecast period. 

To know how our report can help streamline your business, Speak to Analyst

By Sequencing Platform

Launch of New Platforms to Boost Next-Generation Sequencing Segment Growth

Based on the sequencing platform, the market is segmented into next-generation sequencing, sanger sequencing, third-generation sequencing, and others.

In 2025, the next-generation sequencing segment held highest sequencing consumables market share, accounting for 80.8% of the market share. The dominant share of the segment is driven by the increasing adoption of NGS and its consumables due to high throughput, affordability and versatile applications in research and clinical testing.

• For instance, in February 2024, Integrated DNA Technologies (IDT) collaborated with Element Biosciences, Inc., to launch new products designed to enhance the efficiency and simplicity of next-generation sequencing (NGS) workflows for users of the AVITI System.

The third-generation sequencing segment is projected to grow at a CAGR of 27.85% over the forecast period. 

By Application

Increasing Launch of New Products for Clinical Diagnosis to Propel Segment’s Growth

Based on application, the market is segmented into drug discovery & development, clinical diagnosis, pharmacogenomics and others.

The clinical diagnosis segment is anticipated to witness a dominant market share over the forecast period. The segment held a 46.4% market share. This driven by growing demand for accurate, rapid, and cost-effective diagnostic tools. Also, new product launches by key players in disease diagnosis are expected to boost the segment’s growth.

• For instance, in November 2025, OGT launched a new NGS panel for Measurable Residual Disease (MRD), the SureSeq Myeloid MRD Plus NGS Panel.

The drug discovery & development segment is projected to grow at a CAGR of 15.09% over the forecast period. 

By End User

Increasing Demand by Hospitals & Diagnostic Laboratories for Diagnostics to boost the Segment’s Growth

Based on end user, the market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes and others.

The hospitals & diagnostic laboratories companies segment held a dominant market share. In 2025, the segment held a 46.5% market share. This is attributed to the increasing adoption of genomic technologies and consumables, driven by their roles in clinical diagnostics, personalized medicine, and disease monitoring—along with rising strategic activities among key players to boost diagnostic solutions and contribute to the segment’s growth.

• For instance, in June 2025, bioMérieux acquired Day Zero Diagnostics to strengthen its NGS and rapid diagnostic solutions, supporting its efforts to combat antibiotic-resistant infections and advance antimicrobial stewardship through innovative technologies.

The pharmaceutical & biotechnology companies segment is projected to grow at a 15.88% CAGR over the forecast period. 

Sequencing Consumables Market Regional Outlook

By geography, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024, valued at USD 6.00 billion, and maintained its leading position in 2025, with a value of USD 5.58 billion. The market in North America is expected to grow due to rising biotechnology research and the presence of key pharma and biotech companies, which are expected to boost adoption and market growth.

U.S. Sequencing Consumables Market

With North America’s substantial contribution and the U.S. dominance in the region, the U.S. market can be estimated at around USD 5.17 billion in 2025, accounting for roughly 39.7% of global sales. The country's growth is driven by advanced genomic research infrastructure and government initiatives to boost biotech activities.

Europe

Europe is projected to grow at 16.62% over the coming years, the second-highest among all regions, and reached a valuation of USD 3.33 billion by 2025. The region’s market growth is driven by government funding for life sciences research, and the focus on developing and launching personalized medicines is expected to boost growth.

U.K. Sequencing Consumables Market

The U.K. market in 2025 reached USD 0.64 billion, representing approximately 4.9% of global revenues.

Germany Sequencing Consumables Market

Germany’s market was valued at USD 0.76 billion in 2025, equivalent to around 5.9% of the global sequencing consumables sales.

Asia Pacific

Asia Pacific reached USD 2.78 billion in 2025 and secure the position of the third-largest region in the market. This regional growth is driven by increasing demand for sequencing reagents to boost research and development activities and propel regional market growth.

Japan Sequencing Consumables Market

The Japan market in 2025 was at USD 0.45 billion, accounting for roughly 2.8% of global revenues.

China Sequencing Consumables Market

China’s market is projected to be one of the largest worldwide, with 2025 valued at USD 0.98 billion, representing roughly 6.0% of global sales.

India Sequencing Consumables Market

The Indian market in 2025 reached USD 0.36 billion, accounting for roughly 2.2% of global sequencing consumables revenues.

Latin America and Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market reached a valuation of USD 0.65 billion in 2025. The rising adoption of biotechnology research and demand for personalized medicine are driving the region’s growth. In the Middle East & Africa, the GCC was valued at USD 0.29 billion in 2025.

COMPETITIVE LANDSCAPE

Key Industry Players

Emphasis on Key Players to Offer Innovative Products to Maintain Their Position

The global sequencing consumables market is highly consolidated, with several established players offering advanced products and geographic reach. Thermo Fisher Scientific Inc. and Illumina, Inc. hold prominent positions due to their large sequencing platform footprints and presence of end-to-end consumables ecosystems in their product portfolios. Other notable players, such as Agilent Technologies, Inc., and QIAGEN, are strengthening their market positions through library prep and target enrichment portfolios that anchor routine workflows.

LIST OF KEY SEQUENCING CONSUMABLES COMPANIES PROFILED

• Thermo Fisher Scientific Inc. (U.S.)
• Illumina, Inc. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• QIAGEN (U.S.)
• Danaher Corporation (U.S.)
• Twist Bioscience Corporation (U.S.)
• Oxford Nanopore Technologies plc (U.K.)
• PacBio (U.S.)
• 10x Genomics, Inc. (U.S.)
• Hoffmann-La Roche Ltd (Switzerland)

KEY INDUSTRY DEVELOPMENTS

• January 2026: 10x Genomics, Inc. collaborated with Brigham & Women's Hospital to analyze peripheral blood samples from patients living with Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Giant Cell Arteritis (GCA) to uncover immune signatures associated with disease activity, flare, remission, and therapeutic response.
• January 2025: Illumina, Inc. updated the NovaSeq X Series, delivering the NovaSeq X single-flow-cell system alongside a cutting-edge software upgrade and new kits.
• October 2024: Illumina, Inc. launched the MiSeq i100 Series of sequencing systems to advance next-generation sequencing (NGS) for labs.
• August 2023: PacBio announced a research collaboration with the University of Washington to study the capabilities of HiFi long-read whole genome sequencing (WGS) to increase diagnostic rates in pediatric patients with genetic conditions.
• March 2022: Thermo Fisher Scientific Inc. launched the CE-IVD-marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in as little as a single day.

REPORT COVERAGE

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation